antigenic MMP peptides (NIH)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantigenic MMP peptides (NIH)
Drug Alias Nameantigenic matrix metalloproteinase inhibitors (NIH)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsAngiogenesis disorderInflammationArthritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderInflammationArthritis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A